tirzepatide vs glp-1 medications comparison GLP-1 Agonist-Induced Delayed Gastric Emptying – A Clinical Pharmacology Perspective Tirzepatide vs Semaglutide: Which Weight

Sabbah E, Savola K, Ebeling T et al (2000) Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes

McGuinness, L

Consumers should discuss compounded medication status, dosing, risks, alternatives, and pharmacy fulfillment with their assigned licensed provider before starting any compounded medication

Comparatively, Glucagon-like Peptide-1 (GLP-1) agonists, such as liraglutide and semaglutide, primarily work by enhancing insulin secretion, inhibiting glucagon release, promoting weight loss, and improving lipid levels

doi: 10.1093/jcag/gwac035

comparing liraglutide 1.2 mg/day + metformin 1000 mg BID with liraglutide 3 mg/day, the combination therapy was effective in reducing fasting glucose and insulin, HOMA-IR, and LDL cholesterol, while only the high dose of liraglutide resulted in a significant improvement of 120 min during OGTT glucose and insulin levels along with a higher weight loss [63]